Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

1592U89

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
Abacavir (1592U89) is a nucleoside inhibitor of human immunodeficiency virus (HIV) type 1 reverse transcriptase (RT). Resistance… Expand
Highly Cited
1999
Highly Cited
1999
ABSTRACT Abacavir (1592U89), a nucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
1998
1998
ABSTRACT The use of combinations of anti-human immunodeficiency virus (anti-HIV) agents targeted to different molecular targets… Expand
1998
1998
L'invention concerne des combinaisons therapeutiques de (-)-(1S, 4R)-4-[2-amino-6- (cyclopropylamino)-9H-purin-9-yl] -2… Expand
Highly Cited
1997
Highly Cited
1997
1592U89, (-)-(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclo pentene-1-methanol, is a carbocyclic nucleoside with… Expand
Highly Cited
1997
Highly Cited
1997
The anabolism of 1592U89, (-)-(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclo pentene-1-methanol, a selective… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Highly Cited
1997
Highly Cited
1997
The carbocyclic nucleoside 1592U89 is a selective inhibitor of the human immunodeficiency virus (HIV), targeting the reverse… Expand
Review
1996
Review
1996
Carbocyclic nucleosides have been the focus of much recent attention in the development of new antitumor and antiviral… Expand
1996
1996
(57) Abstract: The present invention has an anti-HIV activity (1S, 4R) - cis -4- [2-amino-6- (cyclopropylamino) -9H- purin-9-yl… Expand
1996
1996
L'invention concerne des combinaisons therapeutiques de (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene… Expand